logo
Select company
Select metric
$ 4.52MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
27
Sector
49
Industry
39
History
27
$ 1.34Close
$ 0.72 - $ 4.36 52-Week Range
Ticker Information

Ticker

NXL

Company Name

NEXALIN TECHNOLOGY INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

NEXALIN TECHNOLOGY INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NXL - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 4.52M
3/31/2025$ 4.52M
12/31/2024$ 4.52M
9/30/2024$ 4.52M
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 8.55M
3/31/2023$ 8.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEXALIN TECHNOLOGY INC's latest trailing twelve months (TTM) CF - Equity stands at $ 35.97K.
  • Over the past 5 years, NEXALIN TECHNOLOGY INC's average CF - Equity has been $ 3.65M.
  • The median CF - Equity for NEXALIN TECHNOLOGY INC during this period was $ 4.52M
  • NEXALIN TECHNOLOGY INC reached its highest CF - Equity over the past 5 years at $ 8.55M.
  • The lowest CF - Equity recorded by NEXALIN TECHNOLOGY INC in the same timeframe $ 0

NEXALIN TECHNOLOGY INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
AIMD : AINOS INC $ 719.1KPFSA : PROFUSA INC $ -3.86MADGM : ADAGIO MEDICAL HOLDINGS INC $ 0ABP : ABPRO HOLDINGS INC $ 10.36MCOCH : ENVOY MEDICAL INC $ 2.16MHCWB : HCW BIOLOGICS INC $ 6.93MSABS : SAB BIOTHERAPEUTICS INC $ -3HSDT : HELIUS MEDICAL TECHNOLOGIES INC $ 13.18MHSCS : HEARTSCIENCES INC $ 543.83KAIM : AIM IMMUNOTECH INC $ 2.06M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

NXL - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Sep 30, 2023

$ 8.55M

Maximum

Dec 31, 2022

$ 3.65M

Average

$ 4.52M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M